Most men choose active surveillance for low-risk prostate cancer
Jan 22, 2024
Older age, white race, and higher education were patient factors associated with initial active surveillance uptake in an unadjusted analysis.
Improvements in acute, subacute low back pain seen within first six weeks
Jan 22, 2024
Based on very low-certainty evidence, individuals with persistent low back pain have minimal improvements over time.
Ordering palliative care consult by default increases rate of consultation
Jan 22, 2024
The findings were seen in older hospitalized patients with advanced chronic obstructive pulmonary disease, dementia or kidney failure.
QOL outcomes stable with neurostimulation in Parkinson’s disease
Jan 22, 2024
PDQ-8 and ADL worsened in the standard-of-care medication group and remained stable in the stimulation group.
Recall of charcuterie meat expanded amid ongoing Salmonella outbreak
Jan 19, 2024
Cases of Salmonella now have been recorded in 22 states; no deaths have been reported.
Psychotherapy, meds effective to treat depression in patients with heart failure
Jan 19, 2024
Both behavioral activation psychotherapy and antidepressant medication management reduce depressive symptoms by about 50%.
Study IDs proportion of dementia cases attributable to known risk factors
Jan 19, 2024
The population-attributable fraction for nongenetic risk factors combined is similar for men and women, but it varies across racial and ethnic groups.
Telehealth adoption requires nuanced approach beyond simply running cables to rural areas, new report...
By
Aaron Dorman
Jan 19, 2024
Adding broadband access to rural, underserved communities may not be a silver bullet that enables telehealth use, a new study shows.
CCRC outlook not getting worse but also not improving much, Fitch says
By
Kathleen Steele Gaivin
Jan 19, 2024
Fitch Ratings’ outlook for continuing care retirement / life plan communities is “deteriorating,” according to the company’s senior director and sector lead for life plan communities, Margaret...
Simnotrelvir shortens time to resolution of symptoms in COVID-19
Jan 18, 2024
On day 5, the decrease in viral load from baseline was greater in the simnotrelvir group versus the placebo group.